Clinical Trial Update: Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

View source ↗

Summary

Pfizer-sponsored study evaluated cabergoline for compliance with risk minimization activities. The trial, involving Parkinson's disease and hyperprolactinemia, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Parkinson Disease

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Pfizer | Conditions: Parkinson's Disease, Hyperprolactinemia | Status: COMPLETED | Results posted: 2014-03-24